SEARCH LISTED COMPANY
ANY AUS OR NZ COMPANY
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
Level 1, 200 Mary Street Brisbane QLD 4000
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)delisted from the close of trading on Thursday, 18 March 2021, pursuant to Listing rule 17.11. | 18/03/2021 |
we understand AusCann Group Holdings Limited acquired all of the issued shares in CP1 and issued 1.3 fully paid ordinary shares in AusCann for every CannPal share held as at the Scheme record date being 7pm (AEDT) on 15 March 2021 | 18/03/2021 |
Eligible former CannPal shareholders have been issued 1.3 fully paid ordinary shares in AusCann for every CannPal share they held as at the Scheme record date being 7pm (AEDT) on 15 March 2021. AusCann has issued a total of 123,499,753 new ordinary shares in AusCann to former CannPal shareholders as consideration for the transfer of their CannPal shares to AusCann. Eligible former CannPal shareholders will be sent holding statements recording the number of new AusCann shares issued to the holder under the Scheme. | 18/03/2021 |
CannPal Animal Therapeutics Limited today implemented its scheme of arrangement under which CannPal shareholders received 1.3 new fully paid ordinary shares in AusCann for every 1 fully paid ordinary share held in CannPal at 7.00pm (AEDT) on 15 March 2021. All fully paid ordinary shares in CannPal were transferred to AusCann and CannPal is now a wholly owned subsidiary of AusCann and will be removed from the official list of the ASX shortly. | 18/03/2021 |
The securities of CannPal Animal Therapeutics Limited will be suspended from quotation at the close of trading today, Thursday, 11 March 2021, in accordance with Listing Rule 17.2, following lodgement of the Supreme Court of Western Australia's orders with the Australian Securities and Investments Commission approving the scheme of arrangement by which AusCann Group Holdings Limited will acquire all of the issued shares in CP1. | 11/03/2021 |
listed entity carried for record purposes only | 25/10/2017 |
Purchases Sales
| DATE | DIRECTOR | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|
| 09/12/2019 | Layton Mills | 38,337 | $0.115 | $4,409.00 |
| 09/12/2019 | Layton Mills | 44,000 | $0.115 | $5,060.00 |
| 05/12/2019 | Layton Mills | 47,663 | $0.119 | $5,691.00 |
| 21/11/2019 | Geoff Starr | 120,000 | $0.123 | $14,798.00 |
| 24/05/2019 | Layton Mills | 104,500 | $0.145 | $15,153.00 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Geoff Starr | Chairman | 23/04/2017 |
| Layton Mills | Managing Director, CEO | 05/06/2017 |
| Baden Bowen | CFO, Company Secretary | 25/10/2017 |
| Kate Adams | Non Exec Director | 23/04/2017 |
| Rob Clifford | Non Exec Director | 03/02/2017 |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|
Date of first appointment, title may have changed.
